1. "Katherine Panageas"
  2. "Hematologic Malignancies Research"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (7)
Groups
  1. Biostatistics Service (17)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. Epidemiology and Biostatistics (17)
  5. GSK Faculty (17)
  6. Hematologic Malignancies Research (17)

More Groups

People
  1. Katherine Panageas (17)
  2. David Scheinberg (13)
  3. Joseph Jurcic (7)
  4. Peter Maslak (5)
  5. Alexander Lesokhin (4)
  6. George Sgouros (4)

More People

Years
  1. 2023 (1)
  2. 2017 (1)
  3. 2016 (1)
  4. 2014 (1)
  5. 2012 (1)
  6. 2011 (2)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Blood (2)
  3. Clinical Cancer Research (2)
  4. Journal of Nuclear Medicine (2)
  5. Bone Marrow Transplantation (1)
  6. Cancer Immunology Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (4)
  3. American Society of Hematology (2)
  4. Society of Nuclear Medicine (2)
  5. Nature Publishing Group (1)
  6. Rockefeller University Press (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neopeptide diversity and similarity to the unmutated immunopeptidome is associated with response to immune checkpoint blockade therapy
    Meeting Abstract

    Klatt, M.; Molvi, Z.; Panageas, K.; Wells, D.; Hellmann, M.; Merghoub, T.; Wolchok, J.; O'Reilly, R.; Keller, U.; Scheinberg, D.
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • A randomized phase II trial of adjuvant galinpepimut-S, WT-1 analogue peptide vaccine, after multimodality therapy for patients with malignant pleural mesothelioma
    Journal Article

    Zauderer, M. G.; Tsao, A. S.; Dao, T.; Panageas, K.; Lai, W. V.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; Ginsberg, M. S.; Gomez, D.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes
    Journal Article

    Kitano, S.; Postow, M. A.; Ziegler, C. G. K.; Kuk, D.; Panageas, K. S.; Cortez, C.; Rasalan, T.; Adamow, M.; Yuan, J. D.; Wong, P.; more...
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma
    Meeting Abstract

    Kitano, S.; Postow, M. A.; Cortez, C.; Rasalan, T.; Gallardo, H. F.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Lesokhin, A. M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • (124)I-huA33 antibody PET of colorectal cancer
    Journal Article

    Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Zanzonico, P.; Smith-Jones, P. M.; Divgi, C. R.; Pryma, D. A.; Ruan, S.; Kemeny, N. E.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Divgi, C. R.; Panageas, K. S.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Sgouros, G.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
    Journal Article

    Nakahara, T.; Uchi, H.; Lesokhin, A. M.; Avogadri, F.; Rizzuto, G. A.; Hirschhorn-Cymerman, D.; Panageas, K. S.; Merghoub, T.; Wolchok, J. D.; Houghton, A. N.
    Blood (2010)

    Fulltext@MSK | Save
  • Self-antigen-specifc CD8(+) T cell precursor frequency determines the quality of the antitumor immune response
    Journal Article

    Rizzuto, G. A.; Merghoub, T.; Hirschhorn-Cymerman, D.; Liu, C.; Lesokhin, A. M.; Sahawneh, D.; Zhong, H.; Panageas, K. S.; Perales, M. A.; Altan-Bonnet, G.; more...
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save